首页> 外文期刊>Internal medicine. >Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.
【24h】

Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.

机译:紫杉醇成功治疗与艾滋病相关的晚期卡波西氏肉瘤。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Kaposi's sarcoma (KS) is the most prevalent AIDS-associated tumor. We report a 44-year-old Japanese man with advanced AIDS-associated KS, which was spread over bilateral pulmonary parenchyma. He was initially treated with combination chemotherapy with a partial response. Upon the recurrence of his KS two months after the completion of the combination chemotherapy, the patient received paclitaxel, which brought about a complete response. Highly active antiretrovial therapy (HAART) was initiated three months before the combination chemotherapy, and the CD4+ T-cell count had risen before starting paclitaxel. His dinical course suggests that paclitaxel was highly effective for KS disease control as previously reported, and that immune restoration with HAART is crucial in the treatment of KS.
机译:卡波济肉瘤(KS)是最常见的艾滋病相关肿瘤。我们报道了一名44岁的日本男子,患有晚期艾滋病相关的KS,该病散布在双侧肺实质中。最初,他接受了部分缓解的联合化疗。联合化疗结束后两个月KS复发后,患者接受了紫杉醇治疗,反应完全。在联合化疗前三个月开始进行高活性抗retretial疗法(HAART),开始紫杉醇治疗前CD4 + T细胞计数增加。他的惯常做法表明,紫杉醇对KS疾病的控制非常有效,如先前报道的那样,而HAART的免疫修复在KS的治疗中至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号